據報美妝公司Estee Lauder早於4月在港裁員最多百人
據《香港01》引述消業內消息人士報道,除早前歐資L'Oreal傳出裁逾200人,另一國際美妝巨頭、美資公司Estee Lauder(雅詩蘭黛)香港分部早在今年4月已裁員不超過100人,並將香港分部與台灣分部合併,目前仍有約1,300名員工。同時,該集團今年已關閉約兩間香港門店,但未來沒有進一步調整計劃。Estee Lauder官網顯示目前在港有21間門店。
報道引述消息人士補充,上述美妝集團裁員「一半是因生意唔好,一半是因整合市場策略,主要係後者」,又指不少美妝集團香港分部均有相同舉措,「大部分已經發生」,當中包括行業另一巨頭SHISEIDO香港分部,也有人事調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.